1.
Magistroni R. Tolvaptan: Clinical Evidence for Slowing the Progression of Autosomal Dominant Polycystic Kidney Disease. G Clin Nefrol Dial [Internet]. 2017 May 17 [cited 2024 Nov. 21];29(2):80-4. Available from: https://journals.aboutscience.eu/index.php/gcnd/article/view/660